Antithrombin III for critically ill patients

Arash Afshari; Jørn Wetterslev; Jesper Sune Brok; Ann Merete Møller

doi:10.1002/14651858.CD005370.pub2

Antithrombin III for critically ill patients

Arash Afshari, Jørn Wetterslev, Jesper Sune Brok, Ann Merete Møller

85 Citations (Scopus)

Abstract

Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.

Original language	English
Journal	Cochrane Database of Systematic Reviews
Issue number	3
Pages (from-to)	CD005370
ISSN	1469-493X
DOIs	https://doi.org/10.1002/14651858.CD005370.pub2
Publication status	Published - 1 Jan 2008

Keywords

Anti-Inflammatory Agents
Anticoagulants
Antithrombin III
Critical Illness
Humans
Randomized Controlled Trials as Topic

Access to Document

10.1002/14651858.CD005370.pub2

Cite this

@article{bb8a6400e80f42249700fad23db3e991,

title = "Antithrombin III for critically ill patients",

abstract = "Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.",

keywords = "Anti-Inflammatory Agents, Anticoagulants, Antithrombin III, Critical Illness, Humans, Randomized Controlled Trials as Topic",

author = "Arash Afshari and J{\o}rn Wetterslev and Brok, \{Jesper Sune\} and M{\o}ller, \{Ann Merete\}",

year = "2008",

month = jan,

day = "1",

doi = "10.1002/14651858.CD005370.pub2",

language = "English",

pages = "CD005370",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Antithrombin III for critically ill patients

AU - Afshari, Arash

AU - Wetterslev, Jørn

AU - Brok, Jesper Sune

AU - Møller, Ann Merete

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.

AB - Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. Antithrombin III (AT III) is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown.

KW - Anti-Inflammatory Agents

KW - Anticoagulants

KW - Antithrombin III

KW - Critical Illness

KW - Humans

KW - Randomized Controlled Trials as Topic

UR - https://www.scopus.com/pages/publications/55049104856

U2 - 10.1002/14651858.CD005370.pub2

DO - 10.1002/14651858.CD005370.pub2

M3 - Journal article

C2 - 18646125

SN - 1469-493X

SP - CD005370

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 3

ER -

Antithrombin III for critically ill patients

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this